CGTX Financials

Cognition Therapeutics Inc - Financial statements & key metrics

Stock Price

$1.19

Market Cap

$106.33M

EPS

$-0.32

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-33.97M

EPS (Diluted)

$-0.86

Balance Sheet Highlights

Total Assets

$30.23M

Total Liabilities

$11.48M

Shareholders Equity

Cash & Equivalents

$25.01M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-28.47M

CapEx

Free Cash Flow

Profitability Metrics

ROE

-0.9%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is CGTX revenue?

View CGTX's income statement for detailed revenue data.

Is CGTX profitable?

CGTX reported a loss of $33.97M in the most recent quarter.

What is CGTX market cap?

CGTX has a market capitalization of $106.33M, making it a small-cap stock.

Does CGTX have debt?

View CGTX's balance sheet for debt information.

What is CGTX cash flow?

Cash flow data is available in the full financial statements.